Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.15% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
RGNX · Mar 31, 2025
REGENXBIO Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-25-069237General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
37.78% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
469.79% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
13.62% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
59.64% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
9.59% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20240/6 normalizedLevel 3Mar 31, 20250/6 normalizedLevel 3Jun 30, 20250/6 normalizedLevel 3Sep 30, 20250/6 normalizedLevel 3Dec 31, 20250/6 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 2.92%
- Current
- 1.15%
- Delta
- -1.77%
- Previous
- -207.76%
- Current
- 37.78%
- Delta
- 245.54%
- Previous
- -280.03%
- Current
- 13.62%
- Delta
- 293.66%
- Previous
- 250.24%
- Current
- 59.64%
- Delta
- -190.60%
- Previous
- 46.16%
- Current
- 9.59%
- Delta
- -36.57%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · RGNX Fundamental State →Has State · REGENXBIO Inc. →Transitioned To · RGNX Fundamental State →Transitioned To · RGNX CAPEX_INTENSITY_DECREASED →Transitioned To · RGNX CASH_GENERATION_INCREASED →Transitioned To · RGNX PROFITABILITY_INCREASED →Transitioned To · RGNX R_AND_D_INTENSITY_DECREASED →Transitioned To · RGNX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.